GENE Therapy Payment Act

Hozzl · 2022-02-08T23:20:34Z

Explore the details of House Bill 5882 GENE Therapy Payment Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/8/2022, 11:20 PM

Congressional Summary of HR 5882

Generating Effective and Novel Evidence for Therapy Payment Act or the GENE Therapy Payment Act

This bill allows state Medicaid programs to pay for certain gene therapy drugs through risk-sharing value-based payment agreements with drug manufacturers. The bill applies to covered outpatient drugs that provide potentially curative treatment for serious or life-threatening rare diseases or conditions after not more than three administrations.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5882

Bill HR 5882 is currently in the status of Bill Introduced since February 12, 2020. Bill HR 5882 was introduced during Congress 116 and was introduced to the House on February 12, 2020. Bill HR 5882's most recent activity was Referred to the House Committee on Energy and Commerce. as of February 12, 2020

Bipartisan Support of Bill HR 5882

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5882

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures

- Appropriations

- Congressional oversight

- Department of Health and Human Services

- Drug safety, medical device, and laboratory regulation

- Drug therapy

- Genetics

- Government studies and investigations

- Health care costs and insurance

- Home and outpatient care

- Intergovernmental relations

- Manufacturing

- Medicaid

- Prescription drugs

- State and local government operations

Alternate Title(s) of Bill HR 5882

GENE Therapy Payment Act

To amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes.

GENE Therapy Payment Act

Generating Effective and Novel Evidence for Therapy Payment Act